Pharmaceutical drug radium 223 dichloride

Ended Awarded Last action

Contract number
VA25017F0713
Awardee
Awarding agency
Obligated
$238,924

Award facts

Contract value 100% obligated
$238,924.26 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cincinnati, OH 45220, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 $52,500
Other Administrative Action P00001 $0
Original award $186,424

About this award

This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, by the Department of Veterans Affairs (VA). The $238,924.26 delivery order contract is for the supply of the radiopharmaceutical drug radium 223 dichloride, which is used in the treatment of prostate cancer. The contract is part of Bayer's $840 million multiple award Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs, as well as a $45 million Blanket Purchase Agreement with the VA National Acquisition Center. These contract vehicles allow Bayer to provide a range of critical pharmaceutical products to various federal agencies, primarily supporting healthcare programs for veterans and active-duty military personnel. This particular award has no set-aside designation, reflecting Bayer's status as a large, foreign-owned business capable of meeting the specialized medical needs of the federal government.

Quick answers

Who was awarded contract VA25017F0713?

VA25017F0713 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on November 22, 2016.

How much is contract VA25017F0713 worth?

The government has obligated $238,924 on VA25017F0713.

Is contract VA25017F0713 an order under another contract?

Yes. VA25017F0713 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA25017F0713 competed?

The extent of competition for VA25017F0713 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award